UMOD and autosomal dominant medullary cystic kidney disease with or without hyperuricemia: These issues are emphasized by the strong interfamilial variability in the progression of ADTKD‐UMOD (Moskowitz et al, 2013; Olinger et al, 2020) and a possible gene‐dosage effect on uromodulin processing (Edwards et al, 2017).